As Lawmakers & Public Health Officials Grapple With How Best to Combat the Opioid Crisis, Medical Marijuana is Emerging as a Safer Tool to Manage Pain
The deadly opioid epidemic shows no signs of slowing down, despite the widespread attention it is finally receiving. At least 1,901 people died from opioid overdoses in New Jersey in 2016.
As lawmakers and public health officials grapple with how best to combat the opioid crisis, medical marijuana is emerging as a safer tool to manage pain. A new report from the National Academies of Sciences, Engineering, and Medicine, which represents one of the most comprehensive studies of recent research on the health effects of cannabis, concluded there is “strong evidence” that cannabis is effective at managing chronic pain in adults relative to a placebo.
More people died from drug overdoses in 2014 than in any year on record. More than six out of ten of the fatal overdoses involved an opioid.
Since 1999, the rate of overdose deaths involving opioids—including prescription both opioid pain relievers and heroin—nearly quadrupled.
From 2000 to 2015, more than 500,000 people died from drug overdoses.
Every day, 91 Americans die from an opioid overdose.
Several factors have contributed to the rapid increase in opioid-related overdoses, including a rise on prescriptions for the potent painkillers. Since 1999, the number of prescription opioids sold in the U.S. nearly quadrupled. However, there has not been an overall change in the amount of pain that Americans report.
The majority of opioid deaths involve individuals with no history of substance abuse. In many cases, opioid addiction starts with a valid prescription after surgery or other medical treatment. Once the opioid medication runs out or becomes too expensive, people often turn to street drugs like heroin.
In 2013, providers wrote nearly a quarter of a billion opioid prescriptions, which is enough for every American adult to have their own bottle of pills. Opioids are also increasingly prescribed for chronic pain. Although they may provide short-term relief, the medications have not proven to be an effective long-term solution.
New Jersey’s Medical Marijuana Program
New Jersey legalized medical marijuana in 2010 with the enactment of the New Jersey Compassionate Use Medical Marijuana Act (the “Act”). The New Jersey Department of Health implemented the Act by creating the New Jersey Medical Marijuana Program (“MMP”). The MMP authorizes approved physicians to disburse up to two ounces of medical marijuana to a registered patient during any 30-day period to treat numerous “debilitating medical conditions,” particularly where conventional treatments are ineffective or exacerbate a patient’s suffering.
The Garden State’s medical marijuana program is one of the strictest in the country.
A physician must certify that a patient has an approved debilitating medical condition to participate in the New Jersey Medicinal Marijuana Program. The current list of qualifying conditions for medical marijuana includes amyotrophic lateral sclerosis (Lou Gehrig’s disease), Multiple Sclerosis, terminal cancer, muscular dystrophy, inflammatory bowel disease, and any terminal illness. Post-traumatic stress disorder (PTSD) was added as an approved condition in 2016.
Research confirms that cannabis can be an effective pain management tool. Moreover, encouraging the prescription of medical marijuana can help curb opioid addiction. Unlike narcotic painkillers, cannabis can’t lead to a fatal overdose. The likelihood of addiction is also much lower.
A 2015 working paper by the National Bureau of Economic Research found that the existence of medical marijuana dispensaries in a state was linked to a 15 to 35 percent decrease in admissions to substance abuse treatment centers. It further found a similar decline in overdose deaths.
In Colorado, legalizing recreational cannabis resulted in a decline in opioid overdose deaths. According to a study published in the American Journal of Public Health, in the two years after Colorado implemented its recreational marijuana law, opioid deaths dropped by 6.5 percent. A 2014 study by the Johns Hopkins Bloomberg School of Public Health found similar results. The researchers estimated that prescription drug overdoses decrease 25 percent in states with medical marijuana programs that allow chronic pain patients to participate. Moreover, the effect of legalizing medical cannabis appeared to grow over time, meaning more lives were saved each additional year after the law was enacted.
While Gov. Chris Christie made the opioid crisis a top priority, he strongly opposed medical marijuana. With a change in leadership in the Garden State, it is more likely that cannabis may be considered as a viable solution to the growing health crisis of opioid overdoses.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Does Your Homeowners Insurance Provide Adequate Coverage?
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Understanding the Importance of a Non-Contingent Offer
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Fred D. Zemel Appointed Chair of Strategic Planning at Scarinci & Hollenbeck, LLC
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Novation Agreement Process: Step-by-Step Guide for Businesses
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
What Is a Trade Secret? Key Elements and Legal Protections Explained
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
What Is Title Insurance? Safeguarding Against Title Defects
If you are considering the purchase of a property, you may wonder — what is title insurance, do I need it, and why do I need it? Even seasoned property owners may question if the added expense and extra paperwork is really necessary, especially considering that people and entities insured by title insurance make fewer […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Can Medicinal Marijuana Help Solve the Opioid Crisis?
Author: Daniel T. McKillop
As Lawmakers & Public Health Officials Grapple With How Best to Combat the Opioid Crisis, Medical Marijuana is Emerging as a Safer Tool to Manage Pain
The deadly opioid epidemic shows no signs of slowing down, despite the widespread attention it is finally receiving. At least 1,901 people died from opioid overdoses in New Jersey in 2016.
As lawmakers and public health officials grapple with how best to combat the opioid crisis, medical marijuana is emerging as a safer tool to manage pain. A new report from the National Academies of Sciences, Engineering, and Medicine, which represents one of the most comprehensive studies of recent research on the health effects of cannabis, concluded there is “strong evidence” that cannabis is effective at managing chronic pain in adults relative to a placebo.
More people died from drug overdoses in 2014 than in any year on record. More than six out of ten of the fatal overdoses involved an opioid.
Since 1999, the rate of overdose deaths involving opioids—including prescription both opioid pain relievers and heroin—nearly quadrupled.
From 2000 to 2015, more than 500,000 people died from drug overdoses.
Every day, 91 Americans die from an opioid overdose.
Several factors have contributed to the rapid increase in opioid-related overdoses, including a rise on prescriptions for the potent painkillers. Since 1999, the number of prescription opioids sold in the U.S. nearly quadrupled. However, there has not been an overall change in the amount of pain that Americans report.
The majority of opioid deaths involve individuals with no history of substance abuse. In many cases, opioid addiction starts with a valid prescription after surgery or other medical treatment. Once the opioid medication runs out or becomes too expensive, people often turn to street drugs like heroin.
In 2013, providers wrote nearly a quarter of a billion opioid prescriptions, which is enough for every American adult to have their own bottle of pills. Opioids are also increasingly prescribed for chronic pain. Although they may provide short-term relief, the medications have not proven to be an effective long-term solution.
New Jersey’s Medical Marijuana Program
New Jersey legalized medical marijuana in 2010 with the enactment of the New Jersey Compassionate Use Medical Marijuana Act (the “Act”). The New Jersey Department of Health implemented the Act by creating the New Jersey Medical Marijuana Program (“MMP”). The MMP authorizes approved physicians to disburse up to two ounces of medical marijuana to a registered patient during any 30-day period to treat numerous “debilitating medical conditions,” particularly where conventional treatments are ineffective or exacerbate a patient’s suffering.
The Garden State’s medical marijuana program is one of the strictest in the country.
A physician must certify that a patient has an approved debilitating medical condition to participate in the New Jersey Medicinal Marijuana Program. The current list of qualifying conditions for medical marijuana includes amyotrophic lateral sclerosis (Lou Gehrig’s disease), Multiple Sclerosis, terminal cancer, muscular dystrophy, inflammatory bowel disease, and any terminal illness. Post-traumatic stress disorder (PTSD) was added as an approved condition in 2016.
Research confirms that cannabis can be an effective pain management tool. Moreover, encouraging the prescription of medical marijuana can help curb opioid addiction. Unlike narcotic painkillers, cannabis can’t lead to a fatal overdose. The likelihood of addiction is also much lower.
A 2015 working paper by the National Bureau of Economic Research found that the existence of medical marijuana dispensaries in a state was linked to a 15 to 35 percent decrease in admissions to substance abuse treatment centers. It further found a similar decline in overdose deaths.
In Colorado, legalizing recreational cannabis resulted in a decline in opioid overdose deaths. According to a study published in the American Journal of Public Health, in the two years after Colorado implemented its recreational marijuana law, opioid deaths dropped by 6.5 percent. A 2014 study by the Johns Hopkins Bloomberg School of Public Health found similar results. The researchers estimated that prescription drug overdoses decrease 25 percent in states with medical marijuana programs that allow chronic pain patients to participate. Moreover, the effect of legalizing medical cannabis appeared to grow over time, meaning more lives were saved each additional year after the law was enacted.
While Gov. Chris Christie made the opioid crisis a top priority, he strongly opposed medical marijuana. With a change in leadership in the Garden State, it is more likely that cannabis may be considered as a viable solution to the growing health crisis of opioid overdoses.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
